Subsequent entry biologics - opportunities and challenges

被引：2
|
作者：
Ghosh, Subrata [1 ]
机构：
[1] Univ Calgary, Dept Med, Div Gastroenterol, Calgary, AB T2N 4N1, Canada
来源：
CANADIAN JOURNAL OF GASTROENTEROLOGY | 2013年 / 27卷 / 10期
关键词：
INFLIXIMAB; DISEASE;
D O I：
10.1155/2013/634176
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：565 / 565
页数：1
相关论文
共 50 条
  • [1] Overview of subsequent entry biologics for the management of inflammatory bowel disease and Canadian Association of Gastroenterology position statement on subsequent entry biologics
    Devlin, Shane M.
    Bressler, Brian
    Bernstein, Charles N.
    Fedorak, Richard N.
    Bitton, Alain
    Singh, Harminder
    Feagan, Brian G.
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 27 (10): : 567 - 571
  • [2] Biologics and cardiac disease: challenges and opportunities
    Ciucci, Giulio
    Colliva, Andrea
    Vuerich, Roman
    Pompilio, Giulio
    Zacchigna, Serena
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2022, 43 (11) : 894 - 905
  • [3] Subsequent entry biologics/biosimilars: a viewpoint from Canada
    Anthony S. Russell
    Vandana Ahluwalla
    Cheryl Barnabe
    Shahin Jamal
    Robert C. Offer
    Wojciech P. Olszynski
    Kam Shojania
    Boulos Haraoui
    [J]. Clinical Rheumatology, 2012, 31 : 1289 - 1292
  • [4] Subsequent entry biologics/biosimilars: a viewpoint from Canada
    Russell, Anthony S.
    Ahluwalla, Vandana
    Barnabe, Cheryl
    Jamal, Shahin
    Offer, Robert C.
    Olszynski, Wojciech P.
    Shojania, Kam
    Haraoui, Boulos
    [J]. CLINICAL RHEUMATOLOGY, 2012, 31 (09) : 1289 - 1292
  • [5] Subsequent Entry Biologics in Canada: Current State of the Science
    Endrenyi, Laszlo
    Jamali, Fakhreddin
    Loebenberg, Raimar
    [J]. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2015, 18 (02): : 177 - 183
  • [6] Preparing for Subsequent Entry Biologics in Dermatology and Rheumatology in Canada
    Papp, Kim
    Bourcier, Marc
    Ho, Vincent
    Burke, Karen
    Haraoui, Boulos
    [J]. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2013, 17 (05) : 340 - 346
  • [7] An introduction to biologics and biosimilars. Part II: Subsequent entry biologics: Biosame or biodifferent?
    Revers, Leigh
    Furczon, Eva
    [J]. CANADIAN PHARMACISTS JOURNAL, 2010, 143 (04) : 184 - 191
  • [8] Challenges and Opportunities in the Oral Delivery of Recombinant Biologics
    Masloh, Solene
    Culot, Maxime
    Gosselet, Fabien
    Chevrel, Anne
    Scapozza, Leonardo
    Zeisser Labouebe, Magali
    [J]. PHARMACEUTICS, 2023, 15 (05)
  • [9] CANADIAN PUBLIC REIMBURSEMENT OF SUBSEQUENT ENTRY BIOLOGICS (SEBS) / BIOSIMILARS
    Siu, E. C.
    Wyatt, G.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A168 - A168
  • [10] Survey of Patient Perspectives on the Introduction of Subsequent Entry Biologics in Canada
    Sekhon, Suneet
    Rai, Raman
    Lau, Arthur
    Vanstone, Lauri
    McClory, Debbie
    Whiskin, Carolyn
    Deamude, Melissa
    Mech, Cynthia
    Shah, Alpesh
    Bensen, William
    [J]. JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1336 - 1337
12345